O'Shaughnessy Asset Management, LLC Verastem, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.02 - $1.83 $15,935 - $28,590	-15,623 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.06 - $2.1 $3,077 - $6,096	-2,903 Reduced 15.67%	15,623 $22,000
Q3 2021 Nov 10, 2021	SELL	$2.54 - $4.07 $906 - $1,452	-357 Reduced 1.89%	18,526 $57,000
Q2 2021 Aug 09, 2021	BUY	$2.57 - $4.85 $48,529 - $91,582	18,883 New	18,883 $77,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $840M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.